| Literature DB >> 33075058 |
Ahmed Tabbabi1, Abraham G Cáceres2,3, T Pershing Bustamante Chauca4, Chisato Seki1, Yanisa Choochartpong5, Daiki Mizushima1, Daisuke S Yamamoto1, Yoshihisa Hashiguchi6, Hirotomo Kato1.
Abstract
Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis of the mannose phosphate isomerase (mpi) gene was applied to 134 skin samples collected from patients with cutaneous leishmaniasis (CL) in Peru for identification of the infecting parasite at the species level, and the results were compared with those of cytochrome b (cyt b) gene sequencing obtained in previous studies. Although most results (121/134) including 4 hybrids of Leishmania (Viannia) braziliensis and L. (V.) peruviana corresponded to those obtained in the previous study, PCR-RFLP analyses revealed the distribution of putative hybrid strains between L. (V.) peruviana and L. (V.) lainsoni in two samples, which has never been reported. Moreover, parasite strains showing discordance between kinetoplast and nuclear genes (kDNA and nDNA), so-called mito-nuclear discordance, were identified in 11 samples. Of these, six strains had the kDNAs of L. (V.) braziliensis or L. (V.) peruviana and nDNAs of L. (V.) guyanensis, and three strains had the kDNAs of L. (V.) shawi and nDNAs of L. (V.) braziliensis. The rest were identified as mito-nuclear discordance strains having kDNAs of L. (V.) braziliensis or L. (V.) peruviana and nDNAs of L. (V.) lainsoni, and kDNAs of L. (V.) lainsoni and nDNAs of L. (V.) braziliensis. The results demonstrate that Leishmania strains in Peru are genetically more complex than previously considered.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33075058 PMCID: PMC7595639 DOI: 10.1371/journal.pntd.0008797
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1PCR-RFLP analyses of mpi gene fragments from 6 Leishmania species in Peru.
PCR amplification was performed with leishmanial mannose phosphate isomerase (mpi) gene-specific primers, and PCR products were digested with HaeIII (A), Vpak11BI (B), or BstXI (C), and resulting restriction fragment patterns were analyzed by agarose gel electrophoresis. 1. L. (V.) braziliensis, 2. L. (V.) peruviana, 3. a hybrid of L. (V.) braziliensis/L. (V.) peruviana, 4. L. (V.) guyanensis, 5. L. (V.) lainsoni, 6. L. (L.) amazonensis.
Fig 2Geographic distribution of Leishmania species in Peru identified by PCR-RFLP of mpi and sequence analyses of kinetoplast and nuclear DNAs.
(Adapted from a map available at https://commons.wikimedia.org/wiki/File%3APeru_physical_map.svg).
Distribution of Leishmania species by department in Peru.
| Department | Total | |||||||
|---|---|---|---|---|---|---|---|---|
| Lb | Lp | Lg | Ll | La | Lb/Lp | Lp/Ll | ||
| Amazonas | 0 | 1 | 3 (2 | 0 | 0 | 0 | 0 | 4 |
| Ancash | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Apurimac | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 3 |
| Ayacucho | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 5 |
| Cajamarca | 1 | 1 | 0 | 0 | 0 | 3 | 0 | 5 |
| Cusco | 4 (1 | 0 | 0 | 1 | 0 | 0 | 0 | 5 |
| Huanuco | 3 | 0 | 1 | 0 | 0 | 1 | 0 | 5 |
| Junin | 2 (1 | 0 | 3 (1 | 0 | 1 | 0 | 0 | 6 |
| La Libertad | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 8 |
| Lambayeque | 0 | 18 | 0 | 0 | 0 | 0 | 0 | 18 |
| Lima | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 2 |
| Loreto | 3 | 0 | 1 | 1 | 0 | 0 | 0 | 5 |
| Madre de Dios | 24 (1 | 0 | 1 | 2 | 0 | 0 | 0 | 27 |
| Pasco | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 2 |
| Piura | 1 | 10 | 0 | 0 | 0 | 0 | 0 | 11 |
| Puno | 6 (1 | 0 | 1 | 12 | 0 | 0 | 0 | 19 |
| San Martin | 1 | 1 | 6 | 0 | 0 | 0 | 0 | 8 |
| Total | 47 | 44 | 20 | 16 | 1 | 4 | 2 | 134 |
*Parasite species were identified by the PCR-RFLP analysis targeting 807bp mpi gene fragments (S2 Fig) with restriction enzymes HaeIII, VpaK11BI, and BstXI. Lb, L. (V.) braziliensis; Lp, L. (V.) peruviana; Lg, L. (V.) guyanensis; Ll, L. (V.) lainsoni; La, L (L.) amazonensis; Lb/Lp, a putative hybrid of L. (V.) braziliensis and L. (V.) peruviana; Lb/Ll, a putative hybrid of L. (V.) peruviana and L. (V.) lainsoni
#Mito-nuclear discordance was determined by the comparative analysis of nuclear (mpi, hsp70, and 6pgd) and kinetoplast (cyt b and COII-ND1) DNA fragments.
Comparison of Leishmania species identification in Peru targeting kinetoplast and nuclear DNAs.
| Target DNA | Identification | ||||||
|---|---|---|---|---|---|---|---|
| kDNA | Lb or Lp | Lg: 14 | Ll: 16 | Ls: 3 | La: 1 | ||
| nDNA | Lb: 43 | Lp: 44 | Lb/Lp: 4 | Lg: 14 | Ll: 15 | Lb: 3 | La: 1 |
| Lg: 6 | Ll: 1 | Lp/Ll: 2 | Lb: 1 | ||||
| kDNA + nDNA | Lb: 43 | Lp: 44 | Lb/Lp: 4 | Lg: 14 | Ll: 15 | Ls-Lb: 3 | La: 1 |
| Lb,p-Lg: 6 | Lp/Ll: 2 | Ll-Lb: 1 | |||||
| Lb,p-Ll: 1 | |||||||
1)kDNA: kinetoplast DNA, nDNA: nuclear DNA. Parasite species were identified by the sequencing analysis of cyt b gene (kDNA) and by the PCR-RFLP analysis of mpi gene (nDNA) fragments with restriction enzymes HaeIII, VpaK11BI, and BstXI. Mito-nuclear discordance was further determined by the comparative analysis of nDNA (hsp70, and 6pgd) and kDNA (COII-ND1) fragments.
2)Lb: L. (V.) braziliensis, Lp: L. (V.) peruviana, Lg: L. (V.) guyanensis, Ll: L. (V.) lainsoni, Ls: L. (V.) shawi, La: L. (L.) amazonensis, Lb/Lp: a putative hybrid of L. (V.) braziliensis and L. (V.) peruviana, Lp/Ll: a putative hybrid of L. (V.) peruviana and L. (V.) lainsoni, Lb,p-Lg: L. (V.) guyanensis with kDNAs of L. (V.) braziliensis or L. (V.) peruviana, Lb,p-Ll: L. (V.) lainsoni with kDNAs of L. (V.) braziliensis or L. (V.) peruviana, Ll-Lb: L. (V.) braziliensis with L. (V.) lainsoni kDNA, Ls-Lb: L. (V.) braziliensis with L. (V.) shawi kDNA
3)L. (V.) braziliensis and L. (V.) peruviana cannot be differentiated by kDNA sequence analysis.
Fig 3Differentiation between L. (V.) peruviana and L. (V.) lainsoni by PCR-RFLP and direct sequence analyses of mpi gene fragment.
A, B, C. PCR amplification was performed with mpi gene-specific primers and the PCR products were digested with HaeIII (A), Vpak11BI (B), or BstXI (C). 1. L. (V.) peruviana, 2. L. (V.) lainsoni, 3. a hybrid of L. (V.) peruviana and L. (V.) lainsoni. D. Direct sequence analysis showing three among several species-specific polymorphic sites of the Leishmania mpi gene fragment.